Glucommander Pediatrics received FDA Breakthrough Device Designation for IV insulin dosing in hospitalized children younger than 2 years, but remains uncleared.
ISPAD, EASD, and ADA urge pediatric diabetes teams to build center-specific transition policies, use readiness checklists, and ensure timely handoffs to adult clinicians.
Brittany S. Bruggeman, MD, reviews teplizumab (Tzield), islet autoantibody screening, and automated insulin delivery, and how pediatricians can help families.
Bianca Edison, MD, MS, FAAP, FAMSSM, explains why e-bike injuries were more severe than e-scooter injuries and how pediatricians can open safety conversations.
Sleep specialist Rashi Kochhar, MD, explains how consistent bedtimes and wake times can support adequate sleep and daytime functioning during the school year.